Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. - Wikidata - awgldk - TriplyDB

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

http://www.wikidata.org/entity/Q33496713

about

Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria Venous thromboembolic disease Diagnosis and management of paroxysmal nocturnal hemoglobinuria Pesg PNH diagnosis, follow-up and treatment guidelines Clonal hematopoiesis in acquired aplastic anemia Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuria PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.A case of paroxysmal nocturnal hemoglobinuria presenting with intra-abdominal bleeding due to splenic rupture, developing renal infarct.Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.Paroxysmal nocturnal hemoglobinuria in pediatric patients.Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation.Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: A single-center experience in Saudi Arabia.Paroxysmal Nocturnal Hemoglobinuria in the Differential Diagnosis of Thrombocytopenia.Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria.Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes.Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria.Paroxysmal nocturnal haemoglobinuria: nature's gene therapy?The modern management of severe aplastic anaemia.Etiology and consequences of thrombosis in abdominal vessels.Hepatic venous outflow obstruction: three similar syndromes.Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.Farming for spare body parts: silk purse or sow's ear.Paroxysmal nocturnal hemoglobinuria Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria.Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial.Hypercoagulable state testing and malignancy screening following venous thromboembolic events.Paroxysmal nocturnal hemoglobinuria clone in 103 Brazilian patients: diagnosis and classification Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape.New Insights in Abdominal Pain in Paroxysmal Nocturnal Hemoglobinuria (PNH): A MRI Study.Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study Cerebral haemostasis and antiphospholipid antibodies.A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature.Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria.

P2860

Q24193045-B11BE9C1-3FDD-43D0-8363-A3AFA3CEDDCF Q24201126-CE09823A-BD82-40AD-9590-CED41E2895E1 Q24631121-AF703CB6-5DE2-44A7-A61C-53821E4035D2 Q24670119-CDF21939-060B-4FFF-84DC-D3CEDBDE9D17 Q27021868-E0656954-0AE3-4E8B-995B-A750106D5818 Q28079733-B4A8F069-266B-4BF4-8523-BDA955632E5F Q28243221-195574F8-591E-4D55-801E-B2C9E72608BF Q28259136-AD5644DC-5D5F-4BB1-8E5A-AC543E466875 Q30244631-CDA58079-EC83-428B-8AF7-322B1512B692 Q33379600-711011D9-9A37-4B44-8127-7B8D01AC1980 Q33398524-EB20EE16-7D7C-4FA1-82F9-6381F54A6AEF Q33398617-F1D74336-1C30-4D95-BF08-F90BA0745CAD Q33404676-C720D8B3-CC0F-473E-997C-D96BD05D45E0 Q33425335-53CBEEC9-17FD-4FC9-B824-26E21C53A1A1 Q33441281-EC1CE368-6831-446B-852F-07D3F2566BC4 Q33558763-A0E99393-5940-41FB-8F17-52B19E67CA14 Q33604344-7E3A2983-C22E-4CA7-880C-F4693C50B955 Q33672095-2601CB57-D700-4999-BDBF-BE1C205DBE48 Q33886212-D92668F3-4FF7-47D3-96FE-AC649E427818 Q33888594-1A7DAD0A-C5F6-44E8-A0A6-ED8DA9C03B45 Q33918976-41C9779D-413C-494E-AB82-DDC09C9A195F Q33994359-979E9E88-3C26-4C45-AFB9-040AFDD4160D Q34013126-1D80D6BC-5F95-4B97-82C5-62DC3BE305CF Q34099434-29A3E25F-EEBE-4817-91AA-7F1A5B398A33 Q34148715-8700745E-FC31-4E47-8C3B-F76CDC1CEC0F Q34286605-3EFF8369-0F8F-4EAD-BAFA-6CC578F53520 Q34431429-0E7F7DD8-C170-4DBC-A110-DDD308CBD92D Q34434635-7829356C-35AC-414E-8C22-AD5A97CEBA9E Q34516330-315F25E8-FFCC-46BA-9C0F-2238BE296086 Q34626253-60CB7A01-90D4-467D-AA91-D84704610765 Q35179215-8F2A759F-14F4-45DE-8F50-CAEBE717EFAE Q35244400-6ED1462B-147B-4348-88A2-9D5D4FA03504 Q35252156-6EAC99B7-9FDE-4FFA-AE64-D860847CFC1A Q35511727-B949962A-9559-4A49-9ABC-44B914BAAE32 Q35600943-0F3A66D0-6027-47EC-8A12-41F3F05B8D28 Q35625236-5BA883D0-F318-4C8B-A069-83CE6E1DE2FD Q35670980-0A7374FA-9818-410F-A6B8-B41526034149 Q36152811-BF6D4C9B-B89C-4B5E-9D2D-2A12CADEDF8F Q36158746-6830A15E-C353-4B45-96DD-359AFCEA3CA7 Q36188331-6EAFA205-0F9D-4BB5-9683-66548E7D239E

P2860

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

http://www.wikidata.org/entity/Q33496713

description

1996 nî lūn-bûn

@nan

1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@ast

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@en

type

label

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@ast

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@en

prefLabel

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@ast

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@en

P1433

Q33496713-CE89B4BC-0A61-4B26-B92E-01769544ACE5

P1476

Q33496713-92CA8EA4-E4D6-4DF0-A64C-D8EBDF89D485

P2093

Q33496713-15540508-8C62-4D3F-A59F-1B2EA379D146

Q33496713-37216CAA-24A1-444E-BCE8-8ED934040B69

Q33496713-5FEB9BAE-69A9-4E29-B054-C3106E558B66

Q33496713-9143B00F-CE73-4C70-AB64-62B9E89A8695

Q33496713-954FF0D3-52C6-4051-87E4-2DEB81EDD029

Q33496713-A0D9135E-43DE-4D74-8D11-07785CE0F2BA

Q33496713-A50AB7AA-2CEF-4E84-B073-D1E0DD520E4A

Q33496713-A64A8DD6-25EB-4FFD-B928-8702E803D861

Q33496713-BBA0C326-AA2F-46AF-AEAB-309CC422DD82

Q33496713-E2078D71-1E8E-4BD7-A8AC-4564AA03EBE4

P304

Q33496713-6042E4F5-5F8D-44D6-91A0-4A36C46D98AD

P31

Q33496713-D9704037-B237-4E0E-AC47-293A6D7A6816

P356

Q33496713-C3B8150A-DD88-4BBD-A593-22D8232C6C60

P407

Q33496713-2034A5A8-E693-4532-A0A7-616B568443EE

P433

Q33496713-B5A0CD80-F4D6-4639-BD39-02610C5E73A0

P478

Q33496713-01FA3E28-2B68-44C3-A08F-39CDBB9A8CAC

P577

Q33496713-B36158ED-32E1-4B3A-B588-58AC42D09B59

P5875

Q33496713-CF63ECFF-2A53-47A2-B818-16C7A9DAB492

P698

Q33496713-AB7D0F3A-242C-4FE1-87A8-47608A3DBAE1

P356

S0140-6736(95)12360-1

P1433

P1476

Paroxysmal nocturnal haemoglob ...... French Society of Haematology.

@en

P2093

A de Gramont

http://www.w3.org/2001/XMLSchema#string

B Rio

http://www.w3.org/2001/XMLSchema#string

C Rose

http://www.w3.org/2001/XMLSchema#string

E Gluckman

http://www.w3.org/2001/XMLSchema#string

G Socié

http://www.w3.org/2001/XMLSchema#string

H Rochant

http://www.w3.org/2001/XMLSchema#string

J Y Cahn

http://www.w3.org/2001/XMLSchema#string

J Y Mary

http://www.w3.org/2001/XMLSchema#string

M Leporrier

http://www.w3.org/2001/XMLSchema#string

P Heudier

http://www.w3.org/2001/XMLSchema#string

P304

573-577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(95)12360-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

9027

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14427389

http://www.w3.org/2001/XMLSchema#string

P698

8774569

http://www.w3.org/2001/XMLSchema#string